The Great Vaccine Race: Inside the Unprecedented Scramble to Immunize the World Against COVID-19
The cleverest of enemies thrive on surprise attacks. Viruses—and coronaviruses in particular—know this well. Remaining hidden in animal hosts for decades, they mutate steadily, sometimes serendipitously morphing into more effective and efficient infectious agents. When a strain with just the right combination of genetic codes that spell trouble for people makes the leap from animal to human, the ambush begins. Such was the case with SARS-CoV-2, the coronavirus behind COVID-19, and the attack was mostly silent and insidious at first. Many people infected with SARS-CoV-2 remained oblivious as they served as the v...
Source: TIME: Health - September 10, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Magazine Source Type: news

One Dose Of Coronavirus Vaccine Likely Won ’ t Be Enough; ‘ We ’ re Looking At Double Shots ’
cbsoptanon.onScriptsReady(function(cmp){cmp.ot.targetingAllowed(function(a){if(a) AnvatoPlayer("p1").init({"mcp":"cbs","width":"100%","height":"100%","video":"4683970","autoplay":false,"titleVisible":false,"accessKey":"EZqvRyKE7qmqDflDPXIw6U7kKZEA0Vx7","accessControl":{"preview":false},"pInstance":"p1","plugins":{"heartbeat":{"account":"cbslocal-global-unified","publisherId":"cbslocal","jobId...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - August 31, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Syndicated CBSN Boston CNN Coronavirus Coronavirus Vaccine Source Type: news

The Guardian view on African success: a step closer to conquering polio | Editorial
We are tantalisingly close to eradicating the disease. Things may slip backwards because of science, thugs and exponents of ignorancePolio arrives, if it announces itself at all, as a high temperature. Or a sore throat. Maybe a headache, or an upset stomach. It can go within a week or so, and be mistaken for flu. It is transmitted by poor hygiene, largely affects children under five, and many don ’t realise they’ve had it. In 5-10% of cases, however, the virus affects the nerves, paralysing the legs in particular; sometimes it reaches the lungs. For most, this is temporary. For others –30 years ago, this ...
Source: Guardian Unlimited Science - August 30, 2020 Category: Science Authors: Editorial Tags: Polio Vaccines and immunisation Children Pakistan Afghanistan Hepatitis B Taliban Coronavirus outbreak Infectious diseases Health Medical research Science South and Central Asia Society Source Type: news

Lack of continuous infectious disease pandemic research endangers responses
(American Associates, Ben-Gurion University of the Negev) The coronavirus was also studied considerably less than blood borne viruses like Hepatitis B or C and H.I.V. and its research community has less prolific researchers than the other investigated diseases. This translates into limited collaborations and a non-sustained investment in research on coronaviruses. Such a short-lived investment also reduces funding and may slow down important developments such as new drugs, vaccines or preventive strategies. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 17, 2020 Category: International Medicine & Public Health Source Type: news

US obesity epidemic could undermine effectiveness of a Covid-19 vaccine
Vaccines protecting against influenza, hepatitis B and rabies are less effective for obese people. As scientists develop a Covid-19 vaccine, experts say obesity could be an impediment, a sobering prospect for the US, where nearly half of all adults are obese. (Source: CNN.com - Health)
Source: CNN.com - Health - August 5, 2020 Category: Consumer Health News Source Type: news

Birth dose of hepatitis B vaccine cost effective in Ethiopia
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - August 1, 2020 Category: Drugs & Pharmacology Source Type: news

Progress Toward Hepatitis B Control - South-East Asia Region, 2016-2019
This report describes progress of countries in the World Health Organization's South-East Asia region toward reaching 90% hepatitis B vaccination coverage. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - July 30, 2020 Category: American Health Tags: Hepatitis B Hepatitis B Screening Hepatitis B Vaccination MMWR Morbidity & Mortality Weekly Report Source Type: news

Spread of hepatitis B in children under five, lowest in decades: WHO
The global prevalence of potentially-deadly hepatitis B in children under age five, dropped to under one per cent in 2019 – down from five per cent in the pre-vaccine decades between the 1980s and early 2000s, the World Health Organization (WHO) reported on Monday. (Source: UN News Centre - Health, Poverty, Food Security)
Source: UN News Centre - Health, Poverty, Food Security - July 27, 2020 Category: International Medicine & Public Health Source Type: news

The Role of Food Handlers in Hepatitis A Virus Transmission The Role of Food Handlers in Hepatitis A Virus Transmission
How significant is the risk of secondary transmission from hepatitis A-infected food handlers to food establishment customers? Is preemptive vaccination of food handlers warranted?Morbidity & Mortality Weekly Report (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - July 15, 2020 Category: Infectious Diseases Tags: Public Health & Prevention Journal Article Source Type: news

The Hideous Truths Of Testing Vaccines On Humans
Sixty years ago, a monstrous hepatitis experiment was performed on mentally disabled children at Willowbrook State School that raises serious ethical questions about vaccine challenge trials for Covid-19. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 12, 2020 Category: Pharmaceuticals Authors: Leah Rosenbaum, Forbes Staff Tags: Healthcare /healthcare Innovation /innovation Science /science Daily Cover daily-cover Source Type: news

U.S. FDA Approves New Pediatric Formulation of SIRTURO ® (bedaquiline) as Part of Combination Therapy to Treat Children with Pulmonary Multidrug-Resistant Tuberculosis
NEW BRUNSWICK, NJ, May 27, 2020 — The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has granted approval for a new pediatric formulation of SIRTURO® (bedaquiline). SIRTURO® is now indicated for use as part of combination therapy in the treatment of adult and pediatric patients (5 years and older and weighing at least 15 kg) with pulmonary multidrug-resistant tuberculosis (MDR‑TB). In the U.S., the medicine should be reserved for use when an effective treatment regimen cannot otherwise be provided. This indication received acceler...
Source: Johnson and Johnson - May 27, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Tip of the iceberg: Existing racial inequalities in death from COVID-19 will soar
(Florida Atlantic University) Lifesaving innovations for COVID-19 will only markedly increase the already existing racial inequalities, if public health initiatives for equitable dissemination throughout all communities are not immediately developed. The introduction of drugs for HIV, respiratory distress syndrome, and hepatitis C resulted in racial inequalities. Moreover, before the introduction of the Salk polio vaccine in 1952, initially, black Americans experienced significantly lower rates of paralytic polio than white Americans. By 1959, after the widespread distribution of the vaccine, the reverse was true. (Source:...
Source: EurekAlert! - Infectious and Emerging Diseases - May 20, 2020 Category: Infectious Diseases Source Type: news

What Are Potential Complications of Tattooing?
Discussion “Tattooing of skin via deposition of pigment particles and ink ingredients in the dermis changes normal skin into abnormal skin. Fortunately, this often causes no harm and no disease, although with important exceptions.” Tattoos can be inadvertent from road dirt, gunpowder, pencil graphite etc., but most are desired. Tattoos are common in many cultures and over time..They have been increasing in popularity in the United States over the past few years particularly with a younger, wider and more diverse population. Newsweek reported an 18-country study in 2018 which showed 46% of Americans have a tat...
Source: PediatricEducation.org - May 18, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Child vaccinations down in DR Congo, and COVID-19 is not helping: UNICEF
Fewer children are getting vaccinated in the Democratic Republic of the Congo (DRC) and the COVID-19 pandemic is almost certainly going to make matters worse, the United Nations Children’s Fund (UNICEF) says. If the trend continues, it could trigger a resurgence in deadly childhood diseases such as polio, chickenpox, measles, yellow fever, hepatitis B, diphtheria, tetanus, whooping cough and meningitis. (Source: UN News Centre - Health, Poverty, Food Security)
Source: UN News Centre - Health, Poverty, Food Security - May 15, 2020 Category: International Medicine & Public Health Source Type: news

Twinrix (Hepatitis A Inactivated & Hepatitis B (Recombinant) Vaccine) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 27, 2020 Category: Drugs & Pharmacology Source Type: news

Janssen Announces Submission of Two Applications to U.S. FDA Seeking Approval of SIMPONI ARIA ® (golimumab) for the Treatment of Polyarticular Juvenile Idiopathic Arthritis and Juvenile Psoriatic Arthritis
HORSHAM, PA, April 24, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the submission of two supplemental Biologics License Applications (sBLA) to the U.S. Food and Drug Administration (FDA) seeking approval of SIMPONI ARIA® (golimumab) for the treatment of polyarticular juvenile idiopathic arthritis (pJIA) and juvenile psoriatic arthritis (jPsA), in patients two years of age and older in combination with methotrexate. If approved for these indications, SIMPONI ARIA would be the first anti-tumor necrosis factor (TNF)-alpha biologic agent administered by intravenous infusion av...
Source: Johnson and Johnson - April 24, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Roche receives FDA approval for cobas HPV test for use on the cobas 6800/8800 Systems to identify women at risk for cervical cancer
             Basel, 21 April 2020 - Roche (SIX: RO, ROG; OTCQX:RHHBY) today announced US Food and Drug Administration (FDA) approval for the cobas ® HPV test for use on the fully automated, high-throughput cobas® 6800/8800 Systems. The cobas® HPV test identifies women at risk for cervical cancer by detecting the presence of high-risk human papillomavirus (HPV) DNA in cervical samples. Persistent high-risk HPV infections can develop into pre cancerous lesions and, if left untreated, these lesions can progress to cervical cancer.“The approval ...
Source: Roche Media News - April 21, 2020 Category: Pharmaceuticals Source Type: news

FDA accepts Roche ’s New Drug Application for Xofluza (baloxavir marboxil) for the treatment of influenza in children
Basel, 27 March  2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the US Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) as well as two supplemental New Drug Applications (sNDA) for Xofluza® (baloxavir marboxil). The FDA accepted a NDA for a new formulation of Xofluza as one-dose granules for oral suspension (2 mg/mL), potentially offering a more convenient option for children and those who have difficulty swallowing. In addition, the application seeks approval of Xofluza for the treatment of acute uncomplicated influenza in otherwise healthy children aged one to l ess th...
Source: Roche Investor Update - March 27, 2020 Category: Pharmaceuticals Source Type: news

Janssen Announces Health Canada Approval of CABENUVA ™, the First Long-Acting Regimen for the Treatment of HIV
Cork, Ireland, March 20, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that Health Canada has approved CABENUVA™ (cabotegravir and rilpivirine extended release injectable suspensions), the first and only once-monthly, long-acting regimen for the treatment of HIV-1 infection in adults. CABENUVA™ is indicated as a complete regimen for the treatment of HIV-1 infection in adults to replace the current antiretroviral regimen in patients who are virologically stable and suppressed (HIV-1 RNA less than 50 copies per milliliter [mL]). CABENUVA™, a co-packaged kit with ...
Source: Johnson and Johnson - March 20, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Plagues and People – The Coronavirus in a Historical Perspective
By Jan LundiusSTOCKHOLM / ROME, Mar 19 2020 (IPS) The human factor is intimately involved in the origin, spread, and mitigation of the Coronavirus and we cannot afford to ignore that our future existence depends on compassion and cooperation. Response matters! Some quarantined Italians might recall Giovanni Boccaccio´s The Decameron from 1353 in which people escaping the plague are secluded in a villa where they tell stories to each other. Boccaccio introduced his collection of short stories with an eyewitness account of horrifying human suffering in Florence, which in 1348 was struck by a ”pestilence” t...
Source: IPS Inter Press Service - Health - March 19, 2020 Category: International Medicine & Public Health Authors: Jan Lundius Tags: Global Headlines Health Humanitarian Emergencies TerraViva United Nations Women's Health Source Type: news

Hepatitis B prophylaxis in adolescents who present for examination after alleged sexual assault - Jones ME, Tully JM.
AIM: In Australia, the risk of hepatitis B virus (HBV) transmission from single sexual contact is low. This, combined with assumed widespread immunity from vaccination, has resulted in a lack of clarity surrounding the necessity for hepatitis B post-exposu... (Source: SafetyLit)
Source: SafetyLit - March 17, 2020 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Licensure of a New Hexavalent Vaccine for Use in Infants Licensure of a New Hexavalent Vaccine for Use in Infants
A new hexavalent vaccine for use in children aged 6 weeks through 4 years has been approved by the FDA to prevent diphtheria, tetanus, pertussis, polio, Haemophilus influenzae type b, and hepatitis B.Morbidity & Mortality Weekly Report (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - March 2, 2020 Category: Allergy & Immunology Tags: Public Health & Prevention Journal Article Source Type: news

Hexavalent Vaccine Included in Vaccines for Children Program
FRIDAY, Feb. 7, 2020 -- The hexavalent combined diphtheria and tetanus toxoids and acellular pertussis (DTaP) adsorbed, inactivated poliovirus (IPV), Haemophilus influenza type b (Hib) conjugate (meningococcal protein conjugate), and hepatitis B... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 7, 2020 Category: Pharmaceuticals Source Type: news

Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus influenzae Type b Conjugate, and Hepatitis B Vaccine, and Guidance for Use in Infants
A new combination vaccine to prevent diphtheria, tetanus, whooping cough, polio, Haemphilus influenzae type b disease, and hepatitis B has been licensed, but won't be available before 2021. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - February 6, 2020 Category: American Health Tags: Diphtheria Vaccination Hepatitis B Vaccination MMWR Morbidity & Mortality Weekly Report Pertussis Vaccination Tetanus Vaccination Vaccine-Preventable Diseases and Specific Vaccines Whooping cough Source Type: news

ACIP Releases 2020 Child and Adolescent Vaccine Schedule ACIP Releases 2020 Child and Adolescent Vaccine Schedule
Changes include a recommendation for a hepatitis A catch-up vaccination for anyone who wasn't vaccinated as a child.News Alerts (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - February 4, 2020 Category: Infectious Diseases Tags: Infectious Diseases News Alert Source Type: news

Bharat Biotech keen to revive Rs 600 crore TN vaccine complex
With a planned annual capacity of 585 million, the project proposed to make pentavalent, or five-in-one, combination vaccine, BCG vaccine, and vaccines to prevent measles, hepatitis B, human rabies, Hib (haemophilus influenzae type b) and Japanese encephalitis (JE) in the first phase, which was to be commissioned by 2010. (Source: The Economic Times)
Source: The Economic Times - January 3, 2020 Category: Consumer Health News Source Type: news

BOMBSHELL: AIDS was developed as a bioweapon and administered through CDC-approved vaccine trials that targeted GAY men in the 1970s
(Natural News) Did you know that, just prior to the HIV and AIDS epidemic that swept the American homosexual population during the early 1980s, the Centers for Disease Control and Prevention (CDC) had conducted a hepatitis B vaccine experiment that’s believed to have triggered it? Between the years of 1978 and 1981, the CDC specifically... (Source: NaturalNews.com)
Source: NaturalNews.com - December 27, 2019 Category: Consumer Health News Source Type: news

Panacea Biotec bags orders worth USD 24 mn from UN agencies
The vaccine protects children against five deadly diseases, including diphtheria, tetanus and hepatitis B. "Panacea Biotec... has received awards worth USD 24.32 million from U N agencies (Unicef and PAHO) for supply of its Easyfive-TT, a fully liquid WHO prequalified wP-based Pentavalent vaccine (DTwPHepB-Hib)," the company said in a filing to BSE. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 19, 2019 Category: Pharmaceuticals Source Type: news

Strong Data, Local Relationships: The Future of HIV Care in Tanzania Starts Here
By Margarite Nathe, Principal Editor/Writer, IntraHealth International ; Lucy Mphuru, Country Director& Project Director, Tohara Plus Project Lucy Mphuru (center left) talks with health workers and clients at an IntraHealth-supported mobile clinic in Shinyanga that provides voluntary male circumcision services. Photo by Trevor Snapp for IntraHealth International.November 26, 2019Lucy Mphuru has a big job.Every day, she and her team at IntraHealth International in Tanzania work with frontline health workers and government partners to improve health services in a country of 58 million—1.6 million of whom live...
Source: IntraHealth International - November 26, 2019 Category: International Medicine & Public Health Authors: mnathe Tags: HIV & AIDS Community Engagement Leadership and Governance World AIDS Day Health Workforce Systems Source Type: news

Predictors of Immune Response to Hep B Shot ID'd in Lymphoma
MONDAY, Oct. 28, 2019 -- For patients with lymphoma, the dose and frequency of hepatitis B vaccination, sex, Ann Arbor stage, and ibrutinib as part of the chemotherapy regimen are independent factors that affect the impact of the vaccine, according... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 28, 2019 Category: Pharmaceuticals Source Type: news

Hepatitis C Vaccine Blighted, Another in the Works Hepatitis C Vaccine Blighted, Another in the Works
The second-generation vaccine is being developed by one of the members of the research team that first discovered hepatitis C.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - September 10, 2019 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

Hepatitis C Vaccine Disappoints, Another in the Works Hepatitis C Vaccine Disappoints, Another in the Works
The second-generation vaccine is being developed by one of the members of the research team that first discovered hepatitis C.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - September 10, 2019 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

Diabetes and the Flu: A Dangerous Duo
Help keep patients with diabetes healthy this flu season with a few of these quick reminders on vaccination, medication, comorbidities, and more.   (Source: ConsultantLive)
Source: ConsultantLive - September 6, 2019 Category: Internal Medicine Authors: Gregory M. Weiss, MD Tags: Diabetes Hepatitis C Influenza T2 Diabetes Source Type: news

Flu in Adults with Chronic Health Conditions
When it comes to flu vaccination, nearly 50% of US adults don ’t know the benefits. Are your patients among them? (Source: ConsultantLive)
Source: ConsultantLive - September 6, 2019 Category: Internal Medicine Authors: Leo Robert Tags: Hepatitis C Influenza Source Type: news

Hepatitis E vaccine cost  effective in young women in China
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - September 1, 2019 Category: Drugs & Pharmacology Source Type: news

Updates in ID for PCPs: 5 Questions
How prevalent is use of antibiotics without a prescription? Why do patients hesitate to be vaccinated? Plus, 3 more questions on ID research that may affect primary care. (Source: ConsultantLive)
Source: ConsultantLive - August 22, 2019 Category: Internal Medicine Authors: Leo Robert Tags: Hepatitis C Infectious Disease Source Type: news

Premature Babies Lag in Vaccinations
Preterm babies were more than 20 percent less likely to have had required shots by 19 months. (Source: NYT Health)
Source: NYT Health - August 19, 2019 Category: Consumer Health News Authors: Nicholas Bakalar Tags: Premature Babies Babies and Infants Whooping Cough Tetanus Vaccination and Immunization Hepatitis Mumps Measles Source Type: news

Infectious Diseases A--Z: What you should know about hepatitis A
There is a widespread outbreak of hepatitis A in communities across the U.S. "Hepatitis A is a highly contagious virus that can cause infection and inflammation in the liver," says Dr. Stacey Rizza, an infectious diseases specialist at Mayo Clinic. "It's transmitted through food, water, and through an oral-fecal route." Anyone who has not been vaccinated is [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - August 19, 2019 Category: Databases & Libraries Source Type: news

Uganda: Minister Cautions On Hepatitis B Screening
[Monitor] The State minister for Health in-charge of general duties, Ms Sarah Opendi, has cautioned organisations carrying out medical camps against screening for hepatitis B without providing vaccination, urging that this may cause complacency about the disease and lead to loss of lives. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 13, 2019 Category: African Health Source Type: news

Medical News Today: Hepatitis A becomes health emergency in Florida
The state of Florida has declared the current hepatitis A outbreak a 'public health emergency,' and officials encourage inhabitants to get vaccinated. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - August 5, 2019 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

Nigeria: World Hepatitis Day - Nigerians Implored to Be Screened and Vaccinated
[WHO] Abuja, 30 July, 2019 - As Nigeria and other countries commemorate the 2019 World Hepatitis Day (28 July) with the theme "Invest in Eliminating Hepatitis", stakeholders agree that early detection and childhood vaccination will curb the burden of the disease by 2030. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 2, 2019 Category: African Health Source Type: news

Cape Verde: Cabo Verde Sets the Bar for Ending Mother-to-Child Transmission of Viral Hepatitis
[WHO] "Vaccinating is protecting who you love the most. Everyone should do it," implores Orisa Brito, a mother of three children living in Praia, the capital of Cabo Verde. Her youngest child, Lila, is a healthy 5-month-old who received a dose of hepatitis B vaccine within hours of her birth and is due for another dose in a month. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 29, 2019 Category: African Health Source Type: news

Therapeutic Vaccination for Chronic Hepatitis B Therapeutic Vaccination for Chronic Hepatitis B
This review examined the current evidence for the efficacy and safety of therapeutic vaccines compared to no treatment, placebo or standard care in the treatment of chronic hepatitis B.Journal of Viral Hepatitis (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - July 16, 2019 Category: Allergy & Immunology Tags: Gastroenterology Journal Article Source Type: news

Cochrane's 30 under 30: Jenna Patterson
Cochrane is made up of  11,000 members and over 67,000 supporters come from more than 130 countries, worldwide. Our volunteers and contributors are researchers, health professionals, patients, carers, people passionate about improving health outcomes for everyone, everywhere.Cochrane is an incredible community of people who all play their part in improving health and healthcare globally. We believe that by putting trusted evidence at the heart of health decisions we can achieve a world of improved health for all.  Many  of our contributors are young people working with Cochrane ...
Source: Cochrane News and Events - July 15, 2019 Category: Information Technology Authors: Lydia Parsonson Source Type: news

Nanotechnology delivers hepatitis B vaccine
(Funda ç ã o de Amparo à Pesquisa do Estado de S ã o Paulo) X-ray imaging shows that nanostructured silica acts as a protective vehicle to deliver intact antigen to the intestine so that it can trigger an immune response. The material can give rise to a polyvaccine against six diseases. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 11, 2019 Category: International Medicine & Public Health Source Type: news

hepatitis A vaccine (Havrix, Vaqta)
Title: hepatitis A vaccine (Havrix, Vaqta)Category: MedicationsCreated: 3/2/2005 12:00:00 AMLast Editorial Review: 7/2/2019 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - July 2, 2019 Category: Nutrition Source Type: news

Health Highlights: June 28, 2019
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Older Kids Should Get Hepatitis A Vaccine: Expert Panel Hepatitis A vaccinations should be given to more than 2 million older U.S. children, the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 28, 2019 Category: General Medicine Source Type: news

Uganda: Health Officials Accused of Selling Hepatitis B Vaccines
[Monitor] Bulambuli -Residents of Buginyanya Sub-county in Bulambuli District have accused the health workers attached to Buginyanya Health Centre III of extorting money from them when they visit the facility for Hepatitis B vaccination. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - June 24, 2019 Category: African Health Source Type: news

What Infectious Diseases are Important to Consider in Transplantation Patients?
Discussion Transplantation is not a common problem for primary care physicians but when a child’s disease has progressed to end-stage organ failure, transplantation can be the only treatment available. While the primary care provider usually is not involved in the daily management of patients before, during and after transplantation, they can be involved in many areas. These can include providing appropriate primary and acute care, ordering and obtaining necessary medical tests, medications and equipment, assisting with medical insurance, providing medical history and records to consultants, translating medical infor...
Source: PediatricEducation.org - June 24, 2019 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

VBI's shares plunge after hep B vaccine fails secondary goal in late-stage trial
VBI Vaccines Inc said on Monday a late-stage study was unsuccessful in showing two doses of its hepatitis B vaccine were as effective as three doses of an older vaccine from GlaxoSmithKline, sending its shares plunging 66%. (Source: Reuters: Health)
Source: Reuters: Health - June 17, 2019 Category: Consumer Health News Tags: healthNews Source Type: news